CNBC's David Faber reports Abbott Labs is agreeing to buy St. Jude Medical in a cash and stock deal. CNBC's Jim Cramer, weighs in.
Dane Leone, BTIG analyst, discusses Abbott Labs' $25 billion dollar bid for St. Jude for about $85 per share.
Abbott Laboratories is making a $25 billion bid for St. Jude, reports the "Squawk Box" crew.
U.S. stock futures were higher this morning, after Friday's biggest intraday reversal on Wall Street in four years. Stocks in Europe and Japan were sharply higher in Monday trading.
U.S. stock futures were higher this morning, the first day of the final quarter of 2015. Wall Street closed out a negative third quarter and September Wednesday on positive note.